Aptorum Group Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Aptorum Group Ltd
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
/ 
Frequently asked questions
To buy Aptorum Group Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Aptorum Group Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Aptorum Group Ltd is APM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Aptorum Group Ltd has its primary listing on NASDAQ. You can trade Aptorum Group Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Aptorum Group Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Aptorum Group Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Aptorum Group Ltd.